Search results
Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
Insider Monkey via Yahoo Finance· 6 days agoWe recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co (NYSE...
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Envestnet Asset Management Inc.
ETF DAILY NEWS· 2 days agoEnvestnet Asset Management Inc. lessened its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.4% during the 4th quarter, according ...
Bristol-Myers Squibb's Options Frenzy: What You Need to Know - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 15 hours agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Bristol-Myers Squibb BMY . And retail traders should know. We noticed this today ...
Bristol-Myers Squibb Insiders Sold US$1.1m Of Shares Suggesting Hesitancy
Simply Wall St. via Yahoo Finance· 3 days agoOver the past year, many Bristol-Myers Squibb Company (NYSE:BMY) insiders sold a significant stake...
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 7 days agoThe simplest way to benefit from a rising market is to buy an index fund. But if you buy individual...
...Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients - Bristol-Myers ...
Benzinga· 7 days agoOpdivo plus Yervoy combo shows significant survival benefits and higher response rates vs....
I-Mab and Bristol Myers team up for cancer drug trial By Investing.com
Investing.com· 6 days agoI-Mab (NASDAQ: IMAB), a biotechnology firm specializing in cancer immunotherapies, has announced a...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via AOL· 4 days agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
Buy Alert: 3 Penny Stocks That Will Explode in 2024
InvestorPlace· 6 days agoWhen the term penny stocks to buy is thrown around, ideas of high-risk-high-reward, overnight wealth generation and potential scams may come to mind....
Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday?
Benzinga via AOL· 5 days agoBristol-Myers Squibb Co’s (NYSE:BMY) Nivolumab, sold under the brand name Opdivo, is an anti-cancer...